Delehedde, C.; Chocry, M.; Nguyen, C.; Asteian, A.; Robin, M.; Leloup, L.; Cassien, M.; Mercier, A.; Culcasi, M.; Kovacic, H.;
et al. Bifunctional Metformin–Phenolic Hybrids with Improved Anticancer and Antioxidant Properties: Evaluation on Glioma Cells. Int. J. Mol. Sci. 2026, 27, 1259.
https://doi.org/10.3390/ijms27031259
AMA Style
Delehedde C, Chocry M, Nguyen C, Asteian A, Robin M, Leloup L, Cassien M, Mercier A, Culcasi M, Kovacic H,
et al. Bifunctional Metformin–Phenolic Hybrids with Improved Anticancer and Antioxidant Properties: Evaluation on Glioma Cells. International Journal of Molecular Sciences. 2026; 27(3):1259.
https://doi.org/10.3390/ijms27031259
Chicago/Turabian Style
Delehedde, Caroline, Mathieu Chocry, Camille Nguyen, Alice Asteian, Maxime Robin, Ludovic Leloup, Mathieu Cassien, Anne Mercier, Marcel Culcasi, Hervé Kovacic,
and et al. 2026. "Bifunctional Metformin–Phenolic Hybrids with Improved Anticancer and Antioxidant Properties: Evaluation on Glioma Cells" International Journal of Molecular Sciences 27, no. 3: 1259.
https://doi.org/10.3390/ijms27031259
APA Style
Delehedde, C., Chocry, M., Nguyen, C., Asteian, A., Robin, M., Leloup, L., Cassien, M., Mercier, A., Culcasi, M., Kovacic, H., & Pietri, S.
(2026). Bifunctional Metformin–Phenolic Hybrids with Improved Anticancer and Antioxidant Properties: Evaluation on Glioma Cells. International Journal of Molecular Sciences, 27(3), 1259.
https://doi.org/10.3390/ijms27031259
